Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SUKIRTHARAN SINNATHAMBY

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1538138037
CMS profile
115115
Location
DAYTON, OH

General Payments · PY2018–2024

$6,486.63

  • Reported across 171 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$484.80

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $484.80 15

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,419.54 30
PY2019 $1,391.55 39
PY2020 $419.14 24
PY2021 $634.91 23
PY2022 $469.08 17
PY2023 $667.61 23
PY2024 $484.80 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $19.93 09/23/2024 Food and Beverage Undisputed 01/23/2026 1116131380 CMS
Boston Scientific Corporation $23.13 03/06/2024 Food and Beverage Undisputed 01/23/2026 1092506313 CMS
CashFlow Solutions, LLC $10.73 04/26/2024 Food and Beverage Undisputed 01/23/2026 1139260063 CMS
Janssen Pharmaceuticals, Inc $19.62 01/22/2024 Food and Beverage Undisputed 01/23/2026 1078128751 CMS
Janssen Pharmaceuticals, Inc $15.72 02/28/2024 Food and Beverage Undisputed 01/23/2026 1078129147 CMS
Janssen Pharmaceuticals, Inc $15.00 03/04/2024 Food and Beverage Undisputed 01/23/2026 1078129019 CMS
Janssen Pharmaceuticals, Inc $17.73 03/27/2024 Food and Beverage Undisputed 01/23/2026 1078129343 CMS
Janssen Pharmaceuticals, Inc $18.45 08/11/2024 Food and Beverage Undisputed 01/23/2026 1078128735 CMS
Janssen Pharmaceuticals, Inc $124.52 08/21/2024 Food and Beverage Undisputed 01/23/2026 1078129015 CMS
Janssen Pharmaceuticals, Inc $13.40 09/16/2024 Food and Beverage Undisputed 01/23/2026 1078128729 CMS
Janssen Pharmaceuticals, Inc $4.57 09/16/2024 Food and Beverage Undisputed 01/23/2026 1078129253 CMS
PFIZER INC. $14.45 01/19/2024 Food and Beverage Undisputed 01/23/2026 1131540218 CMS
PFIZER INC. $13.34 05/23/2024 Food and Beverage Undisputed 01/23/2026 1131607442 CMS
Philips North America LLC $64.84 02/27/2024 Food and Beverage Undisputed 01/23/2026 1146877835 CMS
Philips North America LLC $109.37 04/12/2024 Food and Beverage Undisputed 01/23/2026 1146877833 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.